145 related articles for article (PubMed ID: 21327926)
1. Adjuvant chemoradiation for resected gastric cancer: a 10-year experience.
Chang AT; Ng WT; Law AL; Ku KM; Lee MC; Lee AW
Gastric Cancer; 2011 Mar; 14(1):63-71. PubMed ID: 21327926
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
3. Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study.
Kundel Y; Purim O; Idelevich E; Lavrenkov K; Man S; Kovel S; Karminsky N; Pfeffer RM; Nisenbaum B; Fenig E; Sulkes A; Brenner B
Radiat Oncol; 2011 Sep; 6():127. PubMed ID: 21958692
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemoradiation for gastric cancer: experience in the Chinese population.
Tsang WK; Leung SF; Chiu SK; Yeung WW; Ng EK; Yeo W; Lam KC; Chiu PW; Ma BB; Kwan WH; Chan AT
Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):333-40. PubMed ID: 17434719
[TBL] [Abstract][Full Text] [Related]
6. The toxicity and outcomes of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected high-risk gastric cancer: results of a single institute.
Yakir R; Luna K; Marc W; Tamar S; Avraham R; Ayala H
Ann Acad Med Singap; 2008 Mar; 37(3):200-4. PubMed ID: 18392298
[TBL] [Abstract][Full Text] [Related]
7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
8. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
9. Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.
Kassam Z; Lockwood G; O'brien C; Brierley J; Swallow C; Oza A; Siu L; Knox JJ; Wong R; Cummings B; Kim J; Moore M; Ringash J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):713-9. PubMed ID: 16626887
[TBL] [Abstract][Full Text] [Related]
10. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
13. Postoperative chemoradiotherapy for gastric cancer.
Park SH; Kim DY; Heo JS; Lim DH; Park CK; Lee KW; Choi SH; Sohn TS; Kim S; Noh JH; Kim YI; Park JO; Kim K; Kim WS; Jung CW; Im YH; Lee MH; Park K; Park CH; Kang WK
Ann Oncol; 2003 Sep; 14(9):1373-7. PubMed ID: 12954575
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.
Hoffman KE; Neville BA; Mamon HJ; Kachnic LA; Katz MS; Earle CC; Punglia RS
Cancer; 2012 Jan; 118(1):248-57. PubMed ID: 21692071
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.
Kollmannsberger C; Budach W; Stahl M; Schleucher N; Hehr T; Wilke H; Schleicher J; Vanhoefer U; Jehle EC; Oechsle K; Trarbach T; Boehlke I; Kanz L; Hartmann JT; Bokemeyer C
Ann Oncol; 2005 Aug; 16(8):1326-33. PubMed ID: 15919686
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario.
Kapoor R; Dracham CB; G Y S; Khosla D; Dey T; Elangovan A; Madan R; Yadav BS; Kumar N
J Gastrointest Cancer; 2021 Jun; 52(2):616-624. PubMed ID: 32535755
[TBL] [Abstract][Full Text] [Related]
17. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.
Oechsle K; Bokemeyer C; Hartmann JT; Budach W; Trarbach T; Stahl M; Boehlke I; Kollmannsberger C;
J Cancer Res Clin Oncol; 2009 Feb; 135(2):163-72. PubMed ID: 18825411
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
Schwartz GK; Winter K; Minsky BD; Crane C; Thomson PJ; Anne P; Gross H; Willett C; Kelsen D
J Clin Oncol; 2009 Apr; 27(12):1956-62. PubMed ID: 19273696
[TBL] [Abstract][Full Text] [Related]
19. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
